Rigosertib in Combination with Azacitidine Modulates Epigenetic Pathways and can Overcome Clinical Resistance to Hypomethylating Agents in Myelodysplastic Syndromes (MDS). (April 2017)

Record Type:: Journal Article
Title:: Rigosertib in Combination with Azacitidine Modulates Epigenetic Pathways and can Overcome Clinical Resistance to Hypomethylating Agents in Myelodysplastic Syndromes (MDS). (April 2017)
Main Title:: Rigosertib in Combination with Azacitidine Modulates Epigenetic Pathways and can Overcome Clinical Resistance to Hypomethylating Agents in Myelodysplastic Syndromes (MDS)
Authors:: Chaurasia, P.
Isoda, F.
Navada, S.
Odchimar-Reissig, R.
Demakos, E.P.
Reddy, E.P.
Silverman, L.R.
Abstract:
Is Part Of:: Leukemia research. Volume 55(2017)Supplement 1
Journal:: Leukemia research
Issue:: Volume 55(2017)Supplement 1
Issue Display:: Volume 55, Issue 1 (2017)
Year:: 2017
Volume:: 55
Issue:: 1
Issue Sort Value:: 2017-0055-0001-0000
Page Start:: S121
Page End:
Publication Date:: 2017-04
Subjects:: Leukemia -- Periodicals
Leukemia -- Periodicals
Leucémie -- Périodiques
Leukemia
Periodicals
Electronic journals
Electronic journals
616.9941905
Journal URLs:: http://www.sciencedirect.com/science/journal/01452126 ↗
http://www.elsevier.com/journals ↗
DOI:: 10.1016/S0145-2126(17)30317-X ↗
Languages:: English
ISSNs:: 0145-2126
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 5185.270000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 439.xml